A growth-hormone-releasing-hormone analog discussed within the GH-axis category.
Sermorelin is an analog of growth-hormone-releasing hormone (GHRH). It has a longer history of clinical use than many peptides in this set.
It is discussed in connection with prompting the body's own growth-hormone release rather than supplying growth hormone directly.
It is described as stimulating the pituitary through the GHRH pathway, with a relatively short duration compared with DAC-modified analogs.
It appears in GH-axis conversations and has been used clinically in defined contexts.
Discussed as an injectable. Any use is a clinical decision made with a professional.
Science. Precision. Potential.
The content on this site is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before making decisions about your health.
We believe in evidence-informed education, transparency, and personal responsibility. Our goal is to provide accurate information so you can make informed choices aligned with your values and health goals.